Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Date and time:  Thursday 06 February, 13:00 hours

Location: Online via Microsoft/Teams

To Join: This is a free event, which will be taking place online via Microsoft Teams. Register

Abstract: In the United Kingdom, women between the ages of 50 and 70 are invited to attend breast cancer screening at 3-yearly intervals. However, around 20% of breast cancers occur in women before the age of 50. Many factors influence a woman’s risk of developing breast cancer including her family history, breast density, and genetics. By predicting women’s risk of breast cancer at a younger age, it may be possible to tailor early screening and preventative interventions to those identified at high risk. This study aimed to explore the preferences of women between the ages of 30 and 39 for a hypothetical breast cancer risk prediction service using a discrete choice experiment. In this seminar, Dr Wright will discuss the results from the study as well has his experience in designing and analysing the survey through integration of R and Qualtrics.

Bio: Dr Stuart Wright is a Research Fellow at the Manchester Centre for Health Economics. His main research interest relates to how to incorporate and quantify the impact of imperfect implementation, uptake, and wider service delivery issues (such as information provision) of interventions into economic evaluations. Dr Wright is particularly interested in implementation issues in cancer early detection, precision medicine and genomics. He is currently supported by a Wellcome Trust early career award for a project titled "Providing Economic Evidence to Inform and Improve the Implementation of Cancer Screening Programmes". This work will build on his thesis which explored how capacity constraints could be incorporated into economic evaluations of examples of precision medicine in breast and non-small cell lung cancer. In his fellowship he will explore how implementation barriers more broadly, and uptake estimated using discrete choice experiments, can be incorporated into economic models.